Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Jeyou Biotechnology is a precision medicine company specializing in molecular diagnostics and next-generation sequencing (NGS) technologies. Founded in 2015 and headquartered in Shanghai, the company focuses on developing high-sensitivity liquid biopsy and tissue-based diagnostic kits for oncology. Its product portfolio includes companion diagnostics for major cancer types such as lung, colorectal, and breast cancer, targeting key biomarkers like EGFR and KRAS. Jeyou Biotech provides comprehensive genomic profiling services to clinical institutions and pharmaceutical partners to support personalized treatment decisions. The company is recognized for its proprietary bioinformatics pipelines and its commitment to advancing early cancer screening and monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Jeyou.